An observational study in Cancer, sponsored by Wake Forest University Health Sciences. Enrolling by invitation at 38 sites in 3 countries. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-05.
Sponsored by Wake Forest University Health Sciences · Observational
This study evaluates health related social needs screening processes in community oncology clinics.
The primary objective of this study is to assess current processes around health related social needs (HRSN) screening among NCORP clinics and categorize clinics based on their implementation of HRSN screening. The primary endpoint will be a detailed understanding of current processes, with attention to variability by key clinic characteristics.
There are 3 parts of the study in which participants can participate in one or all parts (3 total).
Part 1: Participants attend training, complete clinic assessments and observations and may complete an interview on study.
Part 2: Identified clinic staff will be interviewed to discuss factors that influence HRSN screening at their clinic and help develop generalized guidance.
Part 3: Participants attend a co-design workshop and complete surveys on study feasibility.
10,818 studies on the registry are indexed under Neoplasms; 2,324 are open to participants now.
This study's planned enrollment of 144 is below the median of 200 across 2,638 observational studies indexed under Neoplasms.
Browse Neoplasms studies →Wake Forest University Health Sciences is the lead sponsor of 1,351 studies on the registry; 201 are open to participants now.
Of its 332 completed or terminated interventional studies of FDA-regulated products, 251 (76%) have results posted.
Counted across the registry records on this site, refreshed daily.
NCI Community Oncology Research Program (NCORP) clinics
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Part 1
NCORP PRACTICES:
CLINICS:
PRACTICE STAFF:
CLINIC KEY INFORMANT:
Part 3
STAFF WORKSHOP PARTICIPANT:
PATIENT WORKSHOP PARTICIPANT:
Exclusion Criteria:
Part 1
PRACTICE STAFF:
** Unable to understand, read and communicate in English, as the trainings and observations will be documented in English
Part 3
STAFF WORKSHOP PARTICIPANT:
** Unable to understand, read and communicate in English, as the workshop will be conducted in English
PATIENT WORKSHOP PARTICIPANT:
** Unable to understand, read and communicate in English, as the workshop will be conducted in English
Part 1: Participants attend training, complete clinic assessments and observations and may complete an interview on study.
Other: Non-Interventional
Part 2: Identified clinic staff will be interviewed to discuss factors that influence health related social needs (HRSN) screening at their clinic and help develop generalized guidance.
Other: Non-Interventional
Part 3: Participants attend a co-design workshop and complete surveys on study feasibility.
Other: Non-Interventional
Non-interventional study
HRSN screening reach (Part 1)
Determining the perception of the proportion of patients at clinics who are screened for health related social needs (HRSN).
Time frame: From study enrollment to approximately 4 and 16 weeks post initial study training
Barriers and facilitators influencing HRSN screening implementation
Synthesize themes to create a list of barriers and facilitators influencing HRSN screening implementation within high-implementation clinics, moderate-implementation clinics, and low-implementation clinics.
Time frame: From study enrollment to time completion of key informant interviews, approximately within 6 months
Generation of a tailored implementation plan for each participating clinic
Generation (defined for each clinic as completed or not completed) of a tailored implementation plan for each participating clinic in Part 3 that includes (1) adaptations to current HRSN screening and follow-up processes, and (2) potential implementation strategies to enhance HRSN screening implementation.
Time frame: Between time of clinic selection and co-design workshop completion, to be no more than 6 months
Plan to share: Yes — Wake Forest NCORP Research Base is committed to following the NIH Statement on Sharing Research Data (http://grants.nih.gov/grants/guide/notice-files/NOT-OD-03-032.html). As of July 2018, the WF NCORP RB signed an agreement with NCI to contribute de-identified data and data dictionaries from clinical trials conducted through our RB to the NCI NCTN/NCORP data archive within 6 months of primary and non-primary publications of phase II/III and phase III trials to https://nctn-data-archive.nci.nih.gov/. This will become the primary means for sharing raw data, and we will adhere to the guidelines spelled out in the NCTN/NCORP Data Archive Usage Guide. De-identified data from studies not covered by the agreement (e.g., phase II and observational studies) will be made available upon request. All data files will be de-identified. De-identification procedures will meet the HIPAA criteria as detailed in the Code of Federal Regulations, Part 45, Section 164.514.
Time frame: 6 months after publication for a 2 year duration
Access criteria: upon request to NCORP@wakehealth.edu
Data sharing details ↗ · nctn-data-archive.nci.nih.gov
No publications or documents are linked to this record.
Started Nov 2024 (actual). Primary completion is estimated for Aug 2027, 33 months after the start.
Of 1,098 non-industry observational studies under Neoplasms, half reached primary completion within 61 months of starting (the median), counting those still running; a quarter within 24 and three quarters within 227. This study's planned 33 months is below that.
Counting every sponsor, half of 1,246 studies reached it within 58 months; a quarter within 24 and three quarters within 210.
Neoplasms covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Wake Forest University Health Sciences →